Anti-CMV monoclonal antibody (Humabs BioMed/Institute for Research in Biomedicine)

N/A

Report date: 2022/04/11 15:06:15

Base Information

Drug NameAnti-CMV monoclonal antibody (Humabs BioMed/Institute for Research in Biomedicine)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCytomegalovirus (CMV) envelope glycoprotein H inhibitors
TargetsCytomegalovirus (CMV) envelope glycoprotein H
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHumabs Biomed SaInstitute For Research In Biomedicine
China Registration ClassN/A

Develop Information

Active CompaniesHumabs Biomed SaInstitute For Research In Biomedicine
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A